JP Patent

JP5094197B2 — 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物

Assigned to Daiichi Sankyo Healthcare Co Ltd · Expires 2012-12-12 · 13y expired

What this patent protects

Patent listed against azelastine-hydrochloride.

Drugs covered by this patent

azelastine-hydrochloride (AZELASTINE HYDROCHLORIDE)

Patent Metadata

Patent number: JP5094197B2
Jurisdiction: JP
Classification: —
Expires: 2012-12-12
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Healthcare Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.